Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (128 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 13 Oct 2014 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Aditya Birla Sun Life Multi Asset Omni FoF |
|---|---|
| 13 Oct 2014 | ₹100.00 |
| 09 Oct 2015 | ₹112.94 |
| 04 Oct 2016 | ₹128.48 |
| 29 Sep 2017 | ₹143.95 |
| 25 Sep 2018 | ₹147.14 |
| 21 Sep 2019 | ₹151.48 |
| 16 Sep 2020 | ₹170.86 |
| 11 Sep 2021 | ₹224.79 |
| 07 Sep 2022 | ₹228.20 |
| 03 Sep 2023 | ₹257.74 |
| 29 Aug 2024 | ₹336.39 |
| 24 Aug 2025 | ₹350.78 |
| 20 Aug 2026 | ₹410.74 |
| Metric | Aditya Birla Sun Life · Regular · IDCW NAV ₹71.86 Very High risk ★★★☆☆ | Category median FoF Domestic · 128 funds |
|---|---|---|
| +16.79% | +5.71% | |
| +17.68% | +10.60% | |
| +13.37% | +7.04% | |
| +12.59% | +8.12% | |
| +12.66% | +8.44% | |
| +15.46% | — | |
| +12.42% | +9.37% | |
| +12.25% | +8.64% | |
| +12.45% | +8.30% | |
| Risk | ||
| 11.44% | 13.12% | |
| 0.98 | 0.40 | |
| 1.28 | 0.57 | |
| -22.74% | -18.33% | |
| Nifty 500 | — | |
| +6.42% | +0.09% | |
| 0.62 | 0.95 | |
| 79.0% | 92.9% | |
| 31.4% | 81.4% | |
| 1.25% | 0.58% | |
| ₹397.34Cr | ₹372.62Cr | |
| 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 3% | 13% | |
| Vinod Bhat · 7y | — | |
| 13 Oct 2014 | — | |
| — | — | |
| — | — | |
| 1.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.